アメリカの感染症検査市場:分子診断検査、POC検査、免疫診断検査

◆英語タイトル:Infectious Disease Testing Market in the US 2015-2019
◆商品コード:IRTNTR8448
◆発行会社(調査会社):Technavio
◆発行日:2016年1月6日
◆ページ数:66
◆レポート言語:英語
◆レポート形式:pdf
◆納品方法:Eメール
◆調査対象地域:米国
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥252,500見積依頼/購入/質問フォーム
Five UserUSD3,000 ⇒換算¥303,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥404,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※レポート購入後、該当レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。Technavio社の概要及び新刊レポートはこちらでご確認いただけます。



当調査レポートでは、アメリカの感染症検査市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、アメリカの感染症検査市場規模及び予測、用途別分析、技術別分析、製品別分析、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。
【レポートの概要】

About infectious disease testing
Infectious diseases are caused by microorganisms such as viruses, bacteria, fungi, and parasites. Infectious diseases are one of the primary contributors to morbidity and mortality worldwide. According to the CDC, in the US there are more than 1.2 million people living with HIV infection and one in eight are unaware about their condition. In 2013, it was estimated that 47,352 Americans were diagnosed with HIV infection and in the same year 26,688 people were diagnosed with AIDS. Early diagnosis and treatment play an important role to prevent the long-term complications of HIV/AIDS. Molecular testing, POCT, and immunodiagnostics are used for the screening and detection the disease. Infectious diseases increasingly threaten public health and contribute significantly to the rising costs of health care.

Manufacturers are developing diagnostic tests that can provide results in just a few minutes. For example, Alere developed Alere BinaxNOW Influenza A&B Card, which can detect influenza A & B in 15 minutes.

Technavio’s analysts forecast the infectious disease testing market in the US to grow at a CAGR of 5.81% over the period 2014-2019.

[Covered in this report]
The report covers the current scenario and the growth prospects of the infectious disease testing market in the US for the period of 2015-2019. To calculate the market size, we consider the revenue generated from the sales of equipment and consumables from molecular diagnostics, POCT diagnostic devices, and immunodiagnostics, which are used to detect infectious diseases:

The market is segmented based on technology:
• Molecular diagnostic test
• POCT
• Immunodiagnostic test

The POCT for infectious disease is further segmented based on application:
• HIV
• Respiratory
• HAIs
• Sexual health
• Tropical diseases
• Hepatitis

In addition, the market is segmented based on products:
• Equipment
• Consumables

Technavio’s report, Infectious Disease Testing Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report presents the vendor landscape and a corresponding detailed analysis of the five key vendors in the market. The vendor landscape focuses on vendors that provide access to new technologies. The report also outlines the challenges faced by vendors and the market at large, as well as the key trends emerging in the market.

[Key vendors]
• Abbott Diagnostics
• Alere
• Beckman Coulter Diagnostics
• Roche
• Siemens Healthcare

[Other prominent vendors]
• Abaxis
• Acon Laboratories
• Avioq
• BD
• Bio-Rad Laboratories
• Cavidi
• Cepheid
• Chembio Diagnostic Systems
• Clarity Diagnostics
• EMD Millipore
• Epitope Diagnostic
• Gold Standard Diagnostics
• Hologic
• Immunetics
• InBios International
• Life Technologies
• Maxim Biomedical
• Mindray
• OraSure Technologies
• Ortho Clinical Diagnostics
• Quidel Corporation
• Thermo Fisher Scientific
• Trinity Biotech

[Market driver]
• North America free trade agreement
• For a full, detailed list, view our report

[Market challenge]
• Medical device excise tax law
• For a full, detailed list, view our report

[Market trend]
• Development of innovative diagnostics initiatives
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

【レポートの目次】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Market landscape
• Market overview

PART 06: Infectious disease landscape in the US
• Reimbursement in US
• Clinical laboratory improvement amendments (CLIA) waiver from US Food and Drug Administration
• Five forces analysis

PART 07: Market segmentation by technology
• Molecular diagnostic test
• POCT for infectious diseases
• Immunodiagnostic tests

PART 08: Market segmentation by application

PART 09: Market segmentation by product
• Equipment
• Consumables

PART 10: Market drivers
• NAFTA
• Demand for rapid and automated diagnostics
• Shift toward patient-centered model
• Focus on disease management

PART 11: Impact of drivers

PART 12: Market challenges
• Medical device excise tax law
• Increase in globalization
• New microbial diseases

PART 13: Impact of drivers and challenges

PART 14: Market trends
• Development of innovative diagnostics initiatives
• Key role of US Army Medical Research Institute in Diagnostics and Development (USAMRIID)
• Low-cost microfluidic devices for POCT
• Focus on early diagnosis of infectious diseases

PART 15: Vendor landscape
• Competitive scenario
• Abbott Diagnostics
• Alere
• Roche Diagnostics
• Siemens Healthcare
• Beckman Coulter Diagnostics
• Other prominent vendors

PART 16: Key vendor analysis
• Abbott Diagnostics
• Alere
• Beckman Coulter
• Roche Diagnostics
• Siemens Healthcare

PART 17: Appendix
• List of abbreviations

PART 18: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Infectious disease testing market in US 2014-2019 ($ billions)
Exhibit 03: Average Medicare payments for infectious diseases
Exhibit 04: Five forces analysis
Exhibit 05: Segmentation of infectious disease testing market in US based on technology
Exhibit 06: Molecular diagnostic testing market in US 2014-2019 ($ billions)
Exhibit 07: POCT diagnostic testing market for infectious diseases in US 2014-2019 ($ billions)
Exhibit 08: Immunodiagnostic tests for infectious disease market in US 2014-2019 ($ billions)
Exhibit 09: Segmentation of infectious disease market in US by technology 2014
Exhibit 10: POCT for infectious diseases market in US by application
Exhibit 11: Segmentation of POCT for infectious disease market in US 2014
Exhibit 12: Infectious disease testing market in US by product
Exhibit 13: Segmentation of infectious disease testing market in US by product 2014
Exhibit 14: Impact of drivers
Exhibit 15: Impact of drivers and challenges
Exhibit 16: Key Takeaways: Abbott Diagnostics
Exhibit 17: Key takeaways: Alere
Exhibit 18: Key takeaways: Roche Diagnostics
Exhibit 19: Key takeaways: Siemens Healthcare
Exhibit 20: Key takeaways: Beckman Coulter Diagnostics
Exhibit 21: Abbott Diagnostics: Key business offerings
Exhibit 22: Alere: Business segmentation by revenue 2014
Exhibit 23: Alere: Business segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 24: Alere: Geographical segmentation comparison by revenue 2013 and 2014 ($ millions)
Exhibit 25: Beckman Coulter: Business segmentation
Exhibit 26: Roche Diagnostics: Business segmentation by revenue 2014
Exhibit 27: Roche Diagnostics: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 28: Roche Diagnostics: Segmentation of revenue by regions 2014
Exhibit 29: Siemens Healthcare: Business segmentation
Exhibit 30: Siemens Healthcare: Segmentation of revenue by geography 2014



【掲載企業】

Abbott Diagnostics, Alere, Beckman Coulter Diagnostics, Roche, Siemens Healthcare, Abaxis, Acon Laboratories, Avioq, BD, Bio-Rad Laboratories, Cavidi, Cepheid, Chembio Diagnostic Systems, Clarity Diagnostics, EMD Millipore, Epitope Diagnostic, Gold Standard Diagnostics, Hologic, Immunetics, InBios International, Life Technologies, Maxim Biomedical, Mindray, OraSure Technologies, Ortho Clinical Diagnostics, Quidel Corporation, Thermo Fisher Scientific, Trinity Biotech.

【レポートのキーワード】

感染症検査、分子診断検査、POC検査、免疫診断検査、アメリカ、感染症検査装置、感染症診断

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチ(株)はその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチ(株)が翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

★調査レポート[アメリカの感染症検査市場:分子診断検査、POC検査、免疫診断検査]についてメールでお問い合わせはこちら


※世界の市場調査資料 総合販売サイトMarketReport.jpはH&Iグローバルリサーチ株式会社が運営しております。海外進出、グローバル事業戦略策定、新規事業機会の発掘、競合他社の動向把握などに必要な情報やインサイトをお客様にご提供しております。H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。
※当サイトでは2016年09月28日現在 207,701 件の調査レポートを取り扱っております。当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。

◆H&Iグローバルリサーチのお客様(例)◆